Epigenetic mechanisms entered the resistance network through DNMT1 inhibition studies (Differentiation Therapy by Epigenetic Reconditioning, 2018), which restored differentiation phenotypes in resistant HCC stem cells, thereby bridging genomic and functional resistance determinants (Gailhouste et al., 2018). Here, DNMT1 is linked to hepatocellular carcinoma.